Comparison of in vitro activities of 17 antifungal drugs against a panel of 20 dermatophytes by using a microdilution assay

被引：60

作者：

Favre, B ^{[1
]}

Hofbauer, B ^{[1
]}

Hildering, KS ^{[1
]}

Ryder, NS ^{[1
]}

机构：

[1] Novartis Res Inst, Vienna, Austria

来源：

JOURNAL OF CLINICAL MICROBIOLOGY | 2003年 / 41卷 / 10期

关键词：

D O I：

10.1128/JCM.41.10.4817-4819.2003

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The in vitro activities of 17 antifungal drugs against a panel of 20 dermatophytes comprising 6 different species were determined using a microdilution assay according to the NCCLS M38-P method with some modifications. Terbinafine was the most potent systemic drug while tolnaftate and amorolfine were the most active topical agents.

引用

收藏

页码：4817 / 4819

页数：3

相关论文

共 25 条

[1]

[Anonymous], 2000, M38A NAT COMM CLIN L

[2] In vitro activity of posaconazole against clinical isolates of dermatophytes [J].

Barchiesi, F ;

Arzeni, D ;

Camiletti, V ;

Simonetti, O ;

Cellini, A ;

Offidani, AM ;

Scalise, G .

JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (11) :4208-4209

[3]

Del Rosso JQ, 2000, Curr Infect Dis Rep, V2, P438

[4] Testing conditions for determination of minimum fungicidal concentrations of new and established antifungal agents for Aspergillus spp.:: NCCLS Collaborative Study [J].

Espinel-Ingroff, A ;

Fothergill, A ;

Peter, J ;

Rinaldi, MG ;

Walsh, TJ .

JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (09) :3204-3208

[5] In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi [J].

Espinel-Ingroff, A .

JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (03) :954-958

[6] In vitro activities of 10 antifungal drugs against 508 dermatophyte strains [J].

Fernández-Torres, B ;

Carrillo, AJ ;

Martín, E ;

Del Palacio, A ;

Moore, MK ;

Valverde, A ;

Serrano, M ;

Guarro, J .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (09) :2524-2528

[7] In vitro susceptibility to itraconazole, clotrimazole, ketoconazole and terbinafine of 100 isolates of Trichophyton rubrum [J].

Fernández-Torres, B ;

Vázquez-Veiga, H ;

Llovo, X ;

Pereiro, M ;

Guarro, J .

CHEMOTHERAPY, 2000, 46 (06) :390-394

[8]

Georgopoulos A, 1978, Mykosen, V21, P19

[9] Therapeutic options for the treatment of tinea capitis caused by trichophyton species:: Griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole [J].

Gupta, AK ;

Adam, P ;

Dlova, N ;

Lynde, CW ;

Hofstader, S ;

Morar, N ;

Aboobaker, J ;

Summerbell, RC .

PEDIATRIC DERMATOLOGY, 2001, 18 (05) :433-438

[10] Fungicidal versus fungistatic activity of terbinafine and itraconazole: An in vitro comparison [J].

Hazen, KC .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1998, 38 (05) :S37-S41